Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 291
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01626092 | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders | ||
| NCT02309944 | Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | ||
| NCT05308316 | Sugars in Cigarettes | ||
| NCT04514029 | Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel | ||
| NCT01158456 | Metabolism of NNK Among African Americans | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT01505569 | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | ||
| NCT00869323 | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders | ||
| NCT01850888 | MIBG for Refractory Neuroblastoma and Pheochromocytoma | ||
| NCT03789721 | Adrenoleukodystrophy National Registry Study | ||
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | ||
| NCT00005993 | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer | ||
| NCT05634512 | Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH. | ||
| NCT05363267 | NF-1, Nutraceutical Intervention | ||
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | ||
| NCT01593618 | Empowering Cancer Survivors Through Information Technology | ||
| NCT01033552 | Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT00383448 | HSCT for High Risk Inherited Inborn Errors | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer | ||
| NCT02410239 | MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) | ||
| NCT00381888 | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | ||
| NCT01885897 | IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT | ||
| NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | ||
| NCT01566682 | A Multi-Center Trial of the ProLung Test™ | ||
| NCT00258362 | Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT05809557 | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | ||
| NCT00373152 | MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer | ||
| NCT02989844 | Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT | ||
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT05123040 | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids | ||
| NCT03557749 | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies | ||
| NCT01312818 | Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) | ||
| NCT03981705 | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer | ||
| NCT00274846 | Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT02370160 | HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma | ||
| NCT01385423 | Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) | ||
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | ||
| NCT07493538 | MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases | ||
| NCT01370213 | NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases | ||
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | ||
| NCT00617188 | Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer | ||
| NCT02118311 | Treg Cells for AGVHD in Non-myeloablative UCB Transplant | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT02145039 | Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases |
